Literature DB >> 12724284

Caspase-3 and -6 expression and activation are targeted by hormone action in the rat ventral prostate during the apoptotic cell death process.

Asma Omezzine1, Claire Mauduit, Eric Tabone, Naoufel Nabli, Ali Bouslama, Mohamed Benahmed.   

Abstract

Although the apoptotic cell death process in the prostate is known to be under the control of androgens, the key components targeted by the hormones remain to be investigated. In the present study, we report that the expression and the activation of the effector caspases-3 and -6 are under the control of testosterone in the adult rat ventral prostate. By using a model of adult castrated rats supplemented (or not) with androgens, we observed an increase in caspase-3 (3-fold) and -6 (4-fold) mRNA (P < 0.0001) and procaspase-3 (32 kDa) and -6 (34 kDa) protein levels by 3 days and 1 wk, respectively, after castration in the ventral prostate. Castration also induced an increase in the activation of the procaspases in the ventral prostate, since active (cleaved) caspase-3 (17 kDa) and -6 (12 kDa) forms reached maximal levels by 1 wk after castration. Testosterone administration to castrated adult rats prevented the increase in caspase-3 and -6 mRNA as well as in procaspase-3 and -6 and active caspase-3 and -6 levels in the ventral prostate lobe. In contrast, no changes were observed in the initiator caspase-8 mRNA and protein (procaspase and active) levels after castration. No changes in caspase-3 and -6 expression and activation were observed in the dorsolateral and anterior prostate lobes after castration and testosterone supplementation. Together, the present results show that testosterone inhibits apoptosis in the ventral prostate by potentially targeting the transcriptional activity of effector caspase-3 and -6 genes (but not of casapase-8 gene) as well as the cleavage of procaspase-3 and -6 into active enzymes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12724284     DOI: 10.1095/biolreprod.102.012435

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  5 in total

1.  Origanum majorana L. Extract Attenuated Benign Prostatic Hyperplasia in Rat Model: Effect on Oxidative Stress, Apoptosis, and Proliferation.

Authors:  Dalia Mahmoud Abdelmonem Elsherbini; Hailah M Almohaimeed; Mohamed El-Sherbiny; Zuhair M Mohammedsaleh; Nehal M Elsherbiny; Sami A Gabr; Hasnaa Ali Ebrahim
Journal:  Antioxidants (Basel)       Date:  2022-06-11

2.  Expression of X-linked inhibitor of apoptosis protein in human prostate cancer specimens with and without neo-adjuvant hormonal therapy.

Authors:  Shin-ichi Watanabe; Yasuyoshi Miyata; Shigeru Kanda; Takahisa Iwata; Tomayoshi Hayashi; Hiroshi Kanetake; Hideki Sakai
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-28       Impact factor: 4.553

3.  Down-regulation of DcR2 sensitizes androgen-dependent prostate cancer LNCaP cells to TRAIL-induced apoptosis.

Authors:  David Vindrieux; Marie Réveiller; Jacqueline Chantepie; Sadok Yakoub; Catherine Deschildre; Alain Ruffion; Marian Devonec; Mohamed Benahmed; Renée Grataroli
Journal:  Cancer Cell Int       Date:  2011-12-02       Impact factor: 5.722

4.  Guggulsterone Mediated JAK/STAT and PPAR-Gamma Modulation Prevents Neurobehavioral and Neurochemical Abnormalities in Propionic Acid-Induced Experimental Model of Autism.

Authors:  Rishabh Khera; Sidharth Mehan; Sonalika Bhalla; Sumit Kumar; Abdulrahman Alshammari; Metab Alharbi; Satya Sai Sadhu
Journal:  Molecules       Date:  2022-01-28       Impact factor: 4.411

Review 5.  Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic Hyperplasia.

Authors:  Letteria Minutoli; Mariagrazia Rinaldi; Herbert Marini; Natasha Irrera; Giovanni Crea; Cesare Lorenzini; Domenico Puzzolo; Andrea Valenti; Antonina Pisani; Elena B Adamo; Domenica Altavilla; Francesco Squadrito; Antonio Micali
Journal:  Int J Mol Sci       Date:  2016-08-11       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.